China Sunitinib Drug Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on January 26, 2006. Sunitinib was the first cancer drug simultaneously approved for two different indications.

    This report offers an overview of the market trends, drivers, and barriers with respect to the China Sunitinib Drug market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Sunitinib Drug market. Detailed analysis of key players, along with key growth strategies adopted by Sunitinib Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Company 1

    • Company 2

    • Company 3

    • Company 4

    • Company 5

    • Company 6

    • Company 7

    • Company 8

    • Company 9

    • Company 10

    By Type:

    • 25 mg Capsules

    • 50 mg Capsules

    By End-User:

    • Kidney cancer

    • GIST

    • pNET

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Sunitinib Drug Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Sunitinib Drug Market Size and Growth Rate of 25 mg Capsules from 2016 to 2027

    • 1.3.2 China Sunitinib Drug Market Size and Growth Rate of 50 mg Capsules from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Sunitinib Drug Market Size and Growth Rate of Kidney cancer from 2016 to 2027

    • 1.4.2 China Sunitinib Drug Market Size and Growth Rate of GIST from 2016 to 2027

    • 1.4.3 China Sunitinib Drug Market Size and Growth Rate of pNET from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Sunitinib Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Sunitinib Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Sunitinib Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Sunitinib Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Sunitinib Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Sunitinib Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Sunitinib Drug Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Sunitinib Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Sunitinib Drug by Major Types

    • 3.4.1 Market Size and Growth Rate of 25 mg Capsules

    • 3.4.2 Market Size and Growth Rate of 50 mg Capsules

    4 Segmentation of Sunitinib Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Sunitinib Drug by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Sunitinib Drug in Kidney cancer

    • 4.4.2 Market Size and Growth Rate of Sunitinib Drug in GIST

    • 4.4.3 Market Size and Growth Rate of Sunitinib Drug in pNET

    5 Market Analysis by Regions

    • 5.1 China Sunitinib Drug Production Analysis by Regions

    • 5.2 China Sunitinib Drug Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Sunitinib Drug Landscape Analysis

    • 6.1 North China Sunitinib Drug Landscape Analysis by Major Types

    • 6.2 North China Sunitinib Drug Landscape Analysis by Major End-Users

    7 Central China Sunitinib Drug Landscape Analysis

    • 7.1 Central China Sunitinib Drug Landscape Analysis by Major Types

    • 7.2 Central China Sunitinib Drug Landscape Analysis by Major End-Users

    8 South China Sunitinib Drug Landscape Analysis

    • 8.1 South China Sunitinib Drug Landscape Analysis by Major Types

    • 8.2 South China Sunitinib Drug Landscape Analysis by Major End-Users

    9 East China Sunitinib Drug Landscape Analysis

    • 9.1 East China Sunitinib Drug Landscape Analysis by Major Types

    • 9.2 East China Sunitinib Drug Landscape Analysis by Major End-Users

    10 Northeast China Sunitinib Drug Landscape Analysis

    • 10.1 Northeast China Sunitinib Drug Landscape Analysis by Major Types

    • 10.2 Northeast China Sunitinib Drug Landscape Analysis by Major End-Users

    11 Southwest China Sunitinib Drug Landscape Analysis

    • 11.1 Southwest China Sunitinib Drug Landscape Analysis by Major Types

    • 11.2 Southwest China Sunitinib Drug Landscape Analysis by Major End-Users

    12 Northwest China Sunitinib Drug Landscape Analysis

    • 12.1 Northwest China Sunitinib Drug Landscape Analysis by Major Types

    • 12.2 Northwest China Sunitinib Drug Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Company 1

      • 13.1.1 Company 1 Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Company 2

      • 13.2.1 Company 2 Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Company 3

      • 13.3.1 Company 3 Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Company 4

      • 13.4.1 Company 4 Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Company 5

      • 13.5.1 Company 5 Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Company 6

      • 13.6.1 Company 6 Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Company 7

      • 13.7.1 Company 7 Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Company 8

      • 13.8.1 Company 8 Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Company 9

      • 13.9.1 Company 9 Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Company 10

      • 13.10.1 Company 10 Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Sunitinib Drug Market Size and Growth Rate of 25 mg Capsules from 2016 to 2027

    • Figure China Sunitinib Drug Market Size and Growth Rate of 50 mg Capsules from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Sunitinib Drug Market Size and Growth Rate of Kidney cancer from 2016 to 2027

    • Figure China Sunitinib Drug Market Size and Growth Rate of GIST from 2016 to 2027

    • Figure China Sunitinib Drug Market Size and Growth Rate of pNET from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Sunitinib Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Sunitinib Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Sunitinib Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Sunitinib Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Sunitinib Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Sunitinib Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Sunitinib Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Sunitinib Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Sunitinib Drug

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Sunitinib Drug by Different Types from 2016 to 2027

    • Table Consumption Share of Sunitinib Drug by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of 25 mg Capsules

    • Figure Market Size and Growth Rate of 50 mg Capsules

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Sunitinib Drug by Different End-Users from 2016 to 2027

    • Table Consumption Share of Sunitinib Drug by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Kidney cancer

    • Figure Market Size and Growth Rate of GIST

    • Figure Market Size and Growth Rate of pNET

    • Table China Sunitinib Drug Production by Regions

    • Table China Sunitinib Drug Production Share by Regions

    • Figure China Sunitinib Drug Production Share by Regions in 2016

    • Figure China Sunitinib Drug Production Share by Regions in 2021

    • Figure China Sunitinib Drug Production Share by Regions in 2027

    • Table China Sunitinib Drug Consumption by Regions

    • Table China Sunitinib Drug Consumption Share by Regions

    • Figure China Sunitinib Drug Consumption Share by Regions in 2016

    • Figure China Sunitinib Drug Consumption Share by Regions in 2021

    • Figure China Sunitinib Drug Consumption Share by Regions in 2027

    • Table North China Sunitinib Drug Consumption by Types from 2016 to 2027

    • Table North China Sunitinib Drug Consumption Share by Types from 2016 to 2027

    • Figure North China Sunitinib Drug Consumption Share by Types in 2016

    • Figure North China Sunitinib Drug Consumption Share by Types in 2021

    • Figure North China Sunitinib Drug Consumption Share by Types in 2027

    • Table North China Sunitinib Drug Consumption by End-Users from 2016 to 2027

    • Table North China Sunitinib Drug Consumption Share by End-Users from 2016 to 2027

    • Figure North China Sunitinib Drug Consumption Share by End-Users in 2016

    • Figure North China Sunitinib Drug Consumption Share by End-Users in 2021

    • Figure North China Sunitinib Drug Consumption Share by End-Users in 2027

    • Table Central China Sunitinib Drug Consumption by Types from 2016 to 2027

    • Table Central China Sunitinib Drug Consumption Share by Types from 2016 to 2027

    • Figure Central China Sunitinib Drug Consumption Share by Types in 2016

    • Figure Central China Sunitinib Drug Consumption Share by Types in 2021

    • Figure Central China Sunitinib Drug Consumption Share by Types in 2027

    • Table Central China Sunitinib Drug Consumption by End-Users from 2016 to 2027

    • Table Central China Sunitinib Drug Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Sunitinib Drug Consumption Share by End-Users in 2016

    • Figure Central China Sunitinib Drug Consumption Share by End-Users in 2021

    • Figure Central China Sunitinib Drug Consumption Share by End-Users in 2027

    • Table South China Sunitinib Drug Consumption by Types from 2016 to 2027

    • Table South China Sunitinib Drug Consumption Share by Types from 2016 to 2027

    • Figure South China Sunitinib Drug Consumption Share by Types in 2016

    • Figure South China Sunitinib Drug Consumption Share by Types in 2021

    • Figure South China Sunitinib Drug Consumption Share by Types in 2027

    • Table South China Sunitinib Drug Consumption by End-Users from 2016 to 2027

    • Table South China Sunitinib Drug Consumption Share by End-Users from 2016 to 2027

    • Figure South China Sunitinib Drug Consumption Share by End-Users in 2016

    • Figure South China Sunitinib Drug Consumption Share by End-Users in 2021

    • Figure South China Sunitinib Drug Consumption Share by End-Users in 2027

    • Table East China Sunitinib Drug Consumption by Types from 2016 to 2027

    • Table East China Sunitinib Drug Consumption Share by Types from 2016 to 2027

    • Figure East China Sunitinib Drug Consumption Share by Types in 2016

    • Figure East China Sunitinib Drug Consumption Share by Types in 2021

    • Figure East China Sunitinib Drug Consumption Share by Types in 2027

    • Table East China Sunitinib Drug Consumption by End-Users from 2016 to 2027

    • Table East China Sunitinib Drug Consumption Share by End-Users from 2016 to 2027

    • Figure East China Sunitinib Drug Consumption Share by End-Users in 2016

    • Figure East China Sunitinib Drug Consumption Share by End-Users in 2021

    • Figure East China Sunitinib Drug Consumption Share by End-Users in 2027

    • Table Northeast China Sunitinib Drug Consumption by Types from 2016 to 2027

    • Table Northeast China Sunitinib Drug Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Sunitinib Drug Consumption Share by Types in 2016

    • Figure Northeast China Sunitinib Drug Consumption Share by Types in 2021

    • Figure Northeast China Sunitinib Drug Consumption Share by Types in 2027

    • Table Northeast China Sunitinib Drug Consumption by End-Users from 2016 to 2027

    • Table Northeast China Sunitinib Drug Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Sunitinib Drug Consumption Share by End-Users in 2016

    • Figure Northeast China Sunitinib Drug Consumption Share by End-Users in 2021

    • Figure Northeast China Sunitinib Drug Consumption Share by End-Users in 2027

    • Table Southwest China Sunitinib Drug Consumption by Types from 2016 to 2027

    • Table Southwest China Sunitinib Drug Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Sunitinib Drug Consumption Share by Types in 2016

    • Figure Southwest China Sunitinib Drug Consumption Share by Types in 2021

    • Figure Southwest China Sunitinib Drug Consumption Share by Types in 2027

    • Table Southwest China Sunitinib Drug Consumption by End-Users from 2016 to 2027

    • Table Southwest China Sunitinib Drug Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Sunitinib Drug Consumption Share by End-Users in 2016

    • Figure Southwest China Sunitinib Drug Consumption Share by End-Users in 2021

    • Figure Southwest China Sunitinib Drug Consumption Share by End-Users in 2027

    • Table Northwest China Sunitinib Drug Consumption by Types from 2016 to 2027

    • Table Northwest China Sunitinib Drug Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Sunitinib Drug Consumption Share by Types in 2016

    • Figure Northwest China Sunitinib Drug Consumption Share by Types in 2021

    • Figure Northwest China Sunitinib Drug Consumption Share by Types in 2027

    • Table Northwest China Sunitinib Drug Consumption by End-Users from 2016 to 2027

    • Table Northwest China Sunitinib Drug Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Sunitinib Drug Consumption Share by End-Users in 2016

    • Figure Northwest China Sunitinib Drug Consumption Share by End-Users in 2021

    • Figure Northwest China Sunitinib Drug Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Company 1

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 1

    • Figure Sales and Growth Rate Analysis of Company 1

    • Figure Revenue and Market Share Analysis of Company 1

    • Table Product and Service Introduction of Company 1

    • Table Company Profile and Development Status of Company 2

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 2

    • Figure Sales and Growth Rate Analysis of Company 2

    • Figure Revenue and Market Share Analysis of Company 2

    • Table Product and Service Introduction of Company 2

    • Table Company Profile and Development Status of Company 3

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 3

    • Figure Sales and Growth Rate Analysis of Company 3

    • Figure Revenue and Market Share Analysis of Company 3

    • Table Product and Service Introduction of Company 3

    • Table Company Profile and Development Status of Company 4

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 4

    • Figure Sales and Growth Rate Analysis of Company 4

    • Figure Revenue and Market Share Analysis of Company 4

    • Table Product and Service Introduction of Company 4

    • Table Company Profile and Development Status of Company 5

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 5

    • Figure Sales and Growth Rate Analysis of Company 5

    • Figure Revenue and Market Share Analysis of Company 5

    • Table Product and Service Introduction of Company 5

    • Table Company Profile and Development Status of Company 6

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 6

    • Figure Sales and Growth Rate Analysis of Company 6

    • Figure Revenue and Market Share Analysis of Company 6

    • Table Product and Service Introduction of Company 6

    • Table Company Profile and Development Status of Company 7

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 7

    • Figure Sales and Growth Rate Analysis of Company 7

    • Figure Revenue and Market Share Analysis of Company 7

    • Table Product and Service Introduction of Company 7

    • Table Company Profile and Development Status of Company 8

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 8

    • Figure Sales and Growth Rate Analysis of Company 8

    • Figure Revenue and Market Share Analysis of Company 8

    • Table Product and Service Introduction of Company 8

    • Table Company Profile and Development Status of Company 9

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 9

    • Figure Sales and Growth Rate Analysis of Company 9

    • Figure Revenue and Market Share Analysis of Company 9

    • Table Product and Service Introduction of Company 9

    • Table Company Profile and Development Status of Company 10

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 10

    • Figure Sales and Growth Rate Analysis of Company 10

    • Figure Revenue and Market Share Analysis of Company 10

    • Table Product and Service Introduction of Company 10


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.